|
|
|
Volumn , Issue , 2004, Pages
|
|
Pfizer to pay $430 million over promoting drug to doctors.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETIC ACID DERIVATIVE;
ANTICONVULSIVE AGENT;
ARTICLE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LABELING;
ECONOMICS;
ETHICS;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
LEGAL APPROACH;
LEGAL ASPECT;
MARKETING;
PFIZER LTD.;
PHYSICIAN;
POPULAR APPROACH/SOURCE;
UNITED STATES;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
PFIZER LTD.;
POPULAR APPROACH/SOURCE;
ACETIC ACIDS;
ANTICONVULSANTS;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LABELING;
HUMANS;
MARKETING;
PHYSICIANS;
UNITED STATES;
|
|
EID: 4043162039
PISSN: 03624331
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
